NASDAQ · STOCK
Xylem Inc.
$121.14
52W $105.29 – $154.27
61/100
$26.63B
29.2
1.01
Price History (6M)
Executive Summary
5 analysts weighed in with 60% agreement on a bullish lean. Portfolio Manager: Portfolio position concentration is currently healthy. Growth Analyst: Growth rate is decelerating quarter over quarter -- the trend line matters more than the level. Overall recommendation: WATCH.
Bull & Bear Case
Bull Case
- RSI at or above 70 signals overbought conditions — bearish entry bias.
- Positive MACD histogram signals bullish momentum.
- Weekly trend: uptrend.
- Daily downtrend but weekly uptrend — possible early reversal but not yet confirmed on the daily.
- Bullish candlestick pattern(s) detected: Morning Star.
Bear Case
- RSI is overbought at 72.1 — momentum may be exhausted.
AI Investment Committee
Committee Consensus
As of July 11, 2026
Overall Committee Score
61/100
Agreement
57%
Analysts
7
Conviction
Contested
Growth Analyst
bearish
35
/ 100 · Low confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− RSI at 72 is in overbought territory
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
63
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.17 across 6 articles, 14d)
Portfolio Manager
bullish
75
/ 100 · Low confidence
The existing book is healthy enough that position-sizing here is a matter of stock selection, not portfolio constraints
+ Portfolio position concentration is currently healthy
Technical Analysis
RSI (14)
72.1
Overbought
MACD Histogram
0.661
Bullish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$119.36
Resistance
$130.12
Bollinger %B
0.88
Inside Bands
Price vs Moving Averages
EMA 9
$118.49
Above
EMA 21
$116.00
Above
EMA 50
$115.45
Above
EMA 200
$124.52
Below
Fundamental Analysis
Valuation
61
Growth
44
Profitability
50
Financial Health
84
Valuation
P/E Ratio
29.2×
P/B Ratio
2.89×
PEG Ratio
—
Dividend Yield
1.46%
52W High
$154.27
52W Low
$105.29
Quality & Growth
ROE
877.0%
ROA
568.0%
Gross Margin
3861.0%
Operating Margin
1341.0%
Revenue Growth YoY
+573.0%
Debt / Equity
0.18
AI Fundamental Assessment
P/E ratio of 29.2 (moderate relative to a 15-40x range); Price-to-book of 2.9x; Revenue growth (YoY) of 5.7%; EPS growth (YoY) of 8.2%; Return on equity of 8.8%; Return on assets of 5.7%; Net margin of 10.8%; Gross margin of 38.6%; Current ratio of 1.62 (healthy short-term liquidity); Debt-to-equity of 0.18; Most recent quarter beat estimates by 2.2%; EPS growth decelerating (+3.6% -> -21.1% QoQ); Analyst estimates falling over recent quarters
Key Risks
- RSI is overbought at 72.1 — momentum may be exhausted.
This risk summary is generated from quantitative data signals, not qualitative opinion. All investors should conduct their own due diligence. This is not financial advice.
Get the Full XYL Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Mobile